Premier ROE 2012-2023 | PINC
Current and historical return on equity (ROE) values for Premier (PINC) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Premier ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2023-12-31 | $0.17B | $2.39B | 7.10% |
| 2023-09-30 | $0.18B | $2.35B | 7.59% |
| 2023-06-30 | $0.18B | $2.33B | 7.58% |
| 2023-03-31 | $0.18B | $2.34B | 8.04% |
| 2022-12-31 | $0.18B | $2.31B | 7.73% |
| 2022-09-30 | $0.19B | $2.26B | 8.29% |
| 2022-06-30 | $0.27B | $2.25B | 11.71% |
| 2022-03-31 | $0.29B | $2.23B | 12.61% |
| 2021-12-31 | $0.30B | $2.28B | 13.08% |
| 2021-09-30 | $0.26B | $2.33B | 11.81% |
| 2021-06-30 | $0.26B | $2.23B | 11.93% |
| 2021-03-31 | $0.19B | $2.22B | 9.02% |
| 2020-12-31 | $0.48B | $2.17B | 24.20% |
| 2020-09-30 | $-0.01B | $2.14B | -0.32% |
| 2020-06-30 | $0.60B | $1.86B | 34.13% |
| 2020-03-31 | $0.33B | $1.80B | 19.58% |
| 2019-12-31 | $0.26B | $1.67B | 15.56% |
| 2019-09-30 | $1.40B | $1.69B | 83.50% |
| 2019-06-30 | $-0.01B | $1.66B | -0.48% |
| 2019-03-31 | $-0.04B | $1.64B | -2.70% |
| 2018-12-31 | $-0.41B | $1.70B | -26.39% |
| 2018-09-30 | $-0.83B | $1.68B | -54.93% |
| 2018-06-30 | $0.19B | $1.49B | 12.99% |
| 2018-03-31 | $0.20B | $1.40B | 13.65% |
| 2017-12-31 | $0.22B | $1.45B | 29.33% |
| 2017-09-30 | $0.34B | $1.51B | 587.93% |
| 2017-06-30 | $0.08B | $1.48B | -508.47% |
| 2017-03-31 | $0.49B | $-1.41B | -562.75% |
| 2016-12-31 | $0.87B | $-1.35B | 157.90% |
| 2016-09-30 | $0.42B | $1.22B | 36.09% |
| 2016-06-30 | $0.82B | $1.19B | 74.13% |
| 2016-03-31 | $0.63B | $1.15B | 60.36% |
| 2015-12-31 | $-0.04B | $1.08B | -4.22% |
| 2015-09-30 | $-0.02B | $1.01B | -2.21% |
| 2015-06-30 | $-0.87B | $0.96B | -95.82% |
| 2015-03-31 | $-0.29B | $0.94B | -33.89% |
| 2014-12-31 | $0.59B | $0.89B | 74.04% |
| 2014-09-30 | $-3.09B | $0.82B | -418.02% |
| 2014-06-30 | $-2.71B | $0.77B | -449.54% |
| 2014-03-31 | $-3.21B | $0.72B | -633.09% |
| 2013-12-31 | $-3.71B | $0.63B | -1138.91% |
| 2013-09-30 | $0.01B | $0.28B | 2.99% |
| 2013-06-30 | $0.01B | $0.39B | 7.27% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.473B | $1.336B |
| Premier, Inc. operates as a healthcare alliance. The company brings together hospitals, health systems, physicians and other healthcare providers primarily in the United States. It also maintains clinical, financial and outcomes databases. Premier, Inc. is headquartered in Charlotte, North Carolina. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $118.437B | 15.37 |
| Cencora (COR) | United States | $47.600B | 19.00 |
| ICON (ICLR) | Ireland | $24.090B | 23.76 |
| DiDi Global (DIDIY) | China | $22.541B | 0.00 |
| Avantor (AVTR) | United States | $16.537B | 22.78 |
| CochLear (CHEOY) | $13.442B | 0.00 | |
| Viatris (VTRS) | United States | $13.316B | 3.80 |
| Revvity (RVTY) | United States | $12.420B | 21.62 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.132B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.852B | 21.60 |
| Medpace Holdings (MEDP) | United States | $11.849B | 43.07 |
| Natera (NTRA) | United States | $10.908B | 0.00 |
| Solventum (SOLV) | United States | $10.653B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.853B | 51.20 |
| Bausch + Lomb (BLCO) | Canada | $5.029B | 19.34 |
| Doximity (DOCS) | United States | $4.699B | 34.99 |
| Organon (OGN) | United States | $4.568B | 4.42 |
| Progyny (PGNY) | United States | $3.148B | 52.82 |
| Surgery Partners (SGRY) | United States | $3.098B | 28.79 |
| Sotera Health (SHC) | United States | $3.043B | 14.93 |
| Life Times (LTH) | United States | $2.713B | 29.98 |
| GoodRx Holdings (GDRX) | United States | $2.567B | 130.00 |
| Teladoc Health (TDOC) | United States | $2.225B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.137B | 6.91 |
| Agilon Health (AGL) | United States | $2.052B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.758B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.432B | 0.00 | |
| Agiliti (AGTI) | United States | $1.365B | 22.29 |
| NovoCure (NVCR) | Jersey | $1.297B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.935B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.740B | 7.66 |
| Embecta (EMBC) | United States | $0.590B | 3.89 |
| Auna S.A (AUNA) | Luxembourg | $0.554B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.544B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.528B | 0.00 |
| Enhabit (EHAB) | United States | $0.510B | 46.18 |
| MultiPlan (MPLN) | United States | $0.467B | 0.00 |
| CareDx (CDNA) | United States | $0.429B | 0.00 |
| Beauty Health (SKIN) | United States | $0.409B | 0.00 |
| LifeMD (LFMD) | United States | $0.398B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.378B | 0.00 |
| DocGo (DCGO) | United States | $0.350B | 56.00 |
| Sera Prognostics (SERA) | United States | $0.314B | 0.00 |
| ModivCare (MODV) | United States | $0.295B | 3.91 |
| Ascend Wellness Holdings (AAWH) | United States | $0.269B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.240B | 0.00 |
| Sharecare (SHCR) | United States | $0.237B | 0.00 |
| Biodesix (BDSX) | United States | $0.117B | 0.00 |
| So-Young (SY) | China | $0.116B | 39.00 |
| Oncology Institute (TOI) | United States | $0.087B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.065B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| NeueHealth (NEUE) | United States | $0.048B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.039B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.016B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |